Ameriprise Financial Inc Amphastar Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

  • $356 Billion
  • Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 155,146 shares of AMPH stock, worth $3.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155,146
Previous 146,015 6.25%
Holding current value
$3.92 Million
Previous $5.42 Million 17.04%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$26.24 - $38.48 $239,597 - $351,360
9,131 Added 6.25%
155,146 $4.5 Million
Q4 2024

Feb 14, 2025
BUY
$36.84 - $53.4 $52,202 - $75,667
1,417 Added 0.98%
146,015 $5.42 Million
Q3 2024

Nov 14, 2024
BUY
$36.99 - $50.09 $765,138 - $1.04 Million
20,685 Added 16.69%
144,598 $7.02 Million
Q2 2024

Aug 14, 2024
SELL
$38.65 - $43.48 $414,173 - $465,931
-10,716 Reduced 7.96%
123,913 $4.96 Million
Q1 2024

May 15, 2024
SELL
$42.85 - $63.45 $198,224 - $293,519
-4,626 Reduced 3.32%
134,629 $5.91 Million
Q4 2023

Feb 14, 2024
SELL
$44.49 - $62.93 $463,318 - $655,353
-10,414 Reduced 6.96%
139,255 $8.61 Million
Q3 2023

Nov 14, 2023
SELL
$45.51 - $65.0 $622,804 - $889,525
-13,685 Reduced 8.38%
149,669 $6.88 Million
Q2 2023

Aug 14, 2023
SELL
$35.77 - $58.38 $210,506 - $343,566
-5,885 Reduced 3.48%
163,354 $9.39 Million
Q1 2023

May 15, 2023
SELL
$27.99 - $37.92 $156,212 - $211,631
-5,581 Reduced 3.19%
169,239 $6.35 Million
Q4 2022

Feb 14, 2023
SELL
$27.93 - $31.27 $504,806 - $565,173
-18,074 Reduced 9.37%
174,820 $4.9 Million
Q3 2022

Nov 14, 2022
SELL
$27.56 - $37.75 $88,357 - $121,026
-3,206 Reduced 1.63%
192,894 $5.42 Million
Q2 2022

Aug 15, 2022
BUY
$29.79 - $42.29 $247,733 - $351,683
8,316 Added 4.43%
196,100 $6.82 Million
Q1 2022

May 16, 2022
SELL
$22.96 - $36.45 $39,606 - $62,876
-1,725 Reduced 0.91%
187,784 $6.74 Million
Q4 2021

Feb 14, 2022
BUY
$18.14 - $23.29 $19,464 - $24,990
1,073 Added 0.57%
189,509 $4.41 Million
Q3 2021

Nov 15, 2021
SELL
$17.83 - $21.49 $91,539 - $110,329
-5,134 Reduced 2.65%
188,436 $3.58 Million
Q2 2021

Aug 16, 2021
SELL
$17.11 - $20.92 $8,828 - $10,794
-516 Reduced 0.27%
193,570 $3.9 Million
Q1 2021

May 17, 2021
BUY
$17.21 - $20.65 $106,736 - $128,071
6,202 Added 3.3%
194,086 $3.56 Million
Q4 2020

Feb 12, 2021
SELL
$17.76 - $21.24 $1.4 Million - $1.68 Million
-78,876 Reduced 29.57%
187,884 $3.78 Million
Q3 2020

Nov 16, 2020
SELL
$17.99 - $22.22 $452,538 - $558,944
-25,155 Reduced 8.62%
266,760 $5 Million
Q2 2020

Aug 14, 2020
SELL
$14.25 - $22.46 $46,341 - $73,039
-3,252 Reduced 1.1%
291,915 $6.56 Million
Q1 2020

May 15, 2020
SELL
$12.66 - $20.08 $210,852 - $334,432
-16,655 Reduced 5.34%
295,167 $4.38 Million
Q4 2019

Feb 14, 2020
SELL
$17.07 - $20.64 $121,640 - $147,080
-7,126 Reduced 2.23%
311,822 $6.02 Million
Q3 2019

Nov 14, 2019
BUY
$19.12 - $22.62 $2.44 Million - $2.88 Million
127,423 Added 66.53%
318,948 $6.33 Million
Q2 2019

Aug 14, 2019
BUY
$18.92 - $22.96 $10,973 - $13,316
580 Added 0.3%
191,525 $4.04 Million
Q1 2019

May 15, 2019
SELL
$19.46 - $25.28 $1.09 Million - $1.42 Million
-56,132 Reduced 22.72%
190,945 $3.9 Million
Q4 2018

Feb 14, 2019
BUY
$17.72 - $22.51 $929,360 - $1.18 Million
52,447 Added 26.95%
247,077 $4.92 Million
Q3 2018

Nov 14, 2018
SELL
$15.39 - $19.38 $30,164 - $37,984
-1,960 Reduced 1.0%
194,630 $3.74 Million
Q2 2018

Aug 14, 2018
BUY
$14.63 - $19.6 $165,319 - $221,480
11,300 Added 6.1%
196,590 $3 Million
Q1 2018

May 15, 2018
BUY
$17.23 - $20.35 $76,156 - $89,947
4,420 Added 2.44%
185,290 $3.48 Million
Q4 2017

Feb 12, 2018
SELL
$17.76 - $19.75 $60,206 - $66,952
-3,390 Reduced 1.84%
180,870 $3.48 Million
Q3 2017

Nov 07, 2017
BUY
$14.73 - $17.99 $2.71 Million - $3.31 Million
184,260
184,260 $3.29 Million

Others Institutions Holding AMPH

# of Institutions
258
Shares Held
33.6M
Call Options Held
20.8K
Put Options Held
11.6K
View Full List

About Amphastar Pharmaceuticals, Inc.

AMPH Quotes by TradingView
  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.24B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email